PMX-20005

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePMX-20005
Drug Alias Nameangiogenesis inhibitor (PolyMedix)angiogenesis inhibitor (Innovation Pharmaceuticals)angiogenesis inhibitor (Polymedix)PMX-20005
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor receptor antagonistsFibroblast growth factor receptors antagonists
TargetsFibroblast growth factor receptorsVascular endothelial growth factor receptor
Therapy Area/IndicationsInflammationMacular DegenerationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPolymedix Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPolymedix IncInnovation Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsInflammationMacular DegenerationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A